Hygroscopic Handling: As mentioned earlier, peptides can be hygroscopic
GLP-1s can open the door to better health, but true transformation happens when medicine meets education, nourishment and self-care
Regulatory Status and Absence of Human Safety Data As of 2026, retatrutide has not received approval from the MHRA, FDA, EMA, or any other regulatory authority for human use
The FDA will allow continued compounding of semaglutide until later this spring and announced that it will not take action against compounding pharmacies or distributors for tirzepatide until later this spring or when an injunction against the FDA is lifted
Retatrutide phase 2 obesity trial investigators (2023) Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial
Youre not a failure if you need both, says Christine Ren-Fielding, MD, chief of bariatric surgery at NYU Langone